RESUMO
Atopic dermatitis (AD) is a chronic and inflammatory skin disease that can place a significant burden on quality of life for patients. AD most frequently appears under the age of six and although its prevalence is increasing worldwide, therapeutic treatment options are limited. Chlorella vulgaris (CV) is a species of the freshwater green algae genus chlorella, and has been reported to modulate allergy-inducible factors when ingested. Here, we examined the effect of CV supplementation on AD-like symptoms in NC/Nga mice. CV was orally administrated for six weeks while AD-like symptoms were induced via topical application of Dermatophagoides farinae extract (DFE). CV treatment reduced dermatitis scores, epidermal thickness, and skin hydration. Histological analysis also revealed that CV treatment reduced DFE-induced eosinophil and mast cell infiltration into the skin, while analysis of serum chemokine levels indicated that CV treatment downregulated thymus- and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) levels. In addition, CV treatment downregulated mRNA expression levels of IL-4 and IFN-γ. Taken together, these results suggest that CV extract may have potential as a nutraceutical ingredient for the prevention of AD.
Assuntos
Chlorella vulgaris/química , Dermatite Atópica/tratamento farmacológico , Dermatophagoides farinae/patogenicidade , Suplementos Nutricionais/microbiologia , Imunossupressores/administração & dosagem , Animais , Quimiocinas/sangue , Dermatite Atópica/imunologia , Dermatite Atópica/parasitologia , Modelos Animais de Doenças , Esquema de Medicação , Eosinófilos/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Mastócitos/efeitos dos fármacos , CamundongosRESUMO
BACKGROUND: Chlorella is used as a functional food in East Asia and has been shown to enhance immune system function. However, there has been no direct evidence of the suppressive effect of a hot water extract of Chlorella vulgaris (CVE) on histamine-mediated allergic responses. RESULTS: The antihistamine activity of CVE was analysed using rat peritoneal mast cells (RPMCs) stimulated by compound 48/80. For in vivo verification, ovalbumin (OVA)-immunised BALB/c mice were treated with CVE orally. Serum immunoglobulin E (IgE) levels and splenocyte cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA). CVE prevented histamine release through degranulation of mast cells by blocking the uptake of extracellular Ca²âº into RPMCs. Moreover, CVE administration inhibited serum IgE overproduction by OVA via induction of T helper 1 (Th1) skewing that was dependent on interferon-γ (IFN-γ) and interleukin 12 (IL-12) secretion. CONCLUSION: The results of this study clearly demonstrate that CVE acts as an antiallergic dietary agent by suppressing histamine release via its enhancive effect on Th1-related responses.
Assuntos
Antialérgicos/uso terapêutico , Chlorella vulgaris/química , Suplementos Nutricionais , Antagonistas dos Receptores Histamínicos/uso terapêutico , Hipersensibilidade/prevenção & controle , Extratos Vegetais/uso terapêutico , Animais , Antialérgicos/metabolismo , Teste de Degranulação de Basófilos , Sinalização do Cálcio , Células Cultivadas , Modelos Animais de Doenças , Feminino , Antagonistas dos Receptores Histamínicos/metabolismo , Liberação de Histamina , Hipersensibilidade/imunologia , Hipersensibilidade/metabolismo , Hipersensibilidade/patologia , Testes de Liberação de Interferon-gama , Interleucina-12/metabolismo , Mastócitos/citologia , Mastócitos/imunologia , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Extratos Vegetais/metabolismo , Ratos , Células Th1/imunologia , Células Th1/metabolismo , Células Th1/patologiaRESUMO
BACKGROUND/AIMS: In inflammatory bowel disease (IBD), repeated bouts of remission and relapse occur in patients and can impose a risk of colitis-associated cancer. We hypothesized that plant extracts of Atractylodes macrocephala (AM) or Taraxacum herba (TH) may be better than sulfasalazine for treating this disease because these extracts can promote additional regeneration. METHODS: Murine intestinal epithelial IEC-6 cells were pretreated with AM or TH before a lipopolysaccharide (LPS)-induced challenge. Acute colitis was induced with 7 days of dextran sulfate sodium (DSS) in male C57BL/6 mice, and extracts of AM and TH were administered for 2 weeks before DSS administration. RESULTS: In vitro studies demonstrated that AM or TH treatment reduced LPS-induced COX-2 and tumor necrosis factor-α mRNA levels but increased heme oxygenase-1 (HO-1). Oral preadministration of AM and TH rescued mice from DSS-induced colitis by inhibiting inflammatory mediators via inactivated extracellular signal regulated kinase and repressed nuclear factor κB and signal transducer and activator of transcription 3, but the effect was weaker for sulfasalazine than that for the extracts. Anti-inflammatory activities occurred via the inhibition of macrophage and T lymphocyte infiltrations. Unlike sulfasalazine, which did not induce HO-1, TH extracts afforded significant HO-1 induction. CONCLUSIONS: Because the AM or TH extracts were far superior in preventing DSS-induced colitis than sulfasalazine, AM or TH extracts can be considered natural agents that can prevent IBD relapse.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Atractylodes/química , Colite/tratamento farmacológico , Heme Oxigenase-1/biossíntese , Proteínas de Membrana/biossíntese , Fitoterapia , Extratos Vegetais/farmacologia , Taraxacum/química , Animais , Colite/induzido quimicamente , Colite/prevenção & controle , Ciclo-Oxigenase 2/biossíntese , Sulfato de Dextrana , Indução Enzimática/efeitos dos fármacos , Mediadores da Inflamação/antagonistas & inibidores , Lipopolissacarídeos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Prevenção Secundária/métodos , Sulfassalazina/farmacologia , Fator de Necrose Tumoral alfa/biossínteseRESUMO
The biochemical mechanisms of Chlorella vulgaris protection against cadmium (Cd)-induced liver toxicity were investigated in male Sprague-Dawley rats (5 weeks of age, weighing 90-110 g). Forty rats were randomly divided into one control and three groups treated with 10 ppm Cd: one Cd without Chlorella (Cd-0C), one Cd with 5% Chlorella (Cd-5C), and one Cd with 10% Chlorella (Cd-10C) groups. The rats had free access to water and diet for 8 weeks. Body weight gain and relative liver weight were significantly lower in the Cd-0C group than in Cd-5C and Cd-10C groups. Rats in the Cd-0C group had significantly higher hepatic concentrations of Cd and metallothioneins (MTs) than in the Cd-5C or Cd-10C group. The hepatic MT I/II mRNA was expressed in all experimental rats. MT II was more expressed in the Cd-5C and Cd-10C groups than in the Cd-0C group. Morphologically, a higher level of congestion and vacuolation was observed in the livers of the Cd-0C group compared to those of the Cd-5C and Cd-10C groups. Therefore, this study suggests that C. vulgaris has a protective effect against Cd-induced liver damage by reducing Cd accumulation and stimulating the expression of MT II in liver. However, the details of the mechanism of C. vulgaris on liver toxicity remains to be clarified by further studies.
Assuntos
Intoxicação por Cádmio/tratamento farmacológico , Cádmio/metabolismo , Chlorella vulgaris , Hepatopatias/prevenção & controle , Fígado/fisiopatologia , Metalotioneína/genética , Metalotioneína/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Cádmio/toxicidade , Intoxicação por Cádmio/genética , Doença Hepática Induzida por Substâncias e Drogas , Suplementos Nutricionais , Hepatócitos , Hiperemia , Fígado/efeitos dos fármacos , Masculino , Tamanho do Órgão , Pós , RatosRESUMO
BACKGROUND/AIMS: A unicellular algae, Chlorella vulgaris, was used as a biological response modifier. Although hot water extracts of C. vulgaris (CVE) are thought to augment immune responses, the effect of CVE on fatigue and physical stamina has not been studied. METHODS: In the present study, we investigated the effect of CVE on forced swimming test and blood biochemical parameters related to fatigue, blood urea nitrogen (BUN), creatine kinase (CK), lactic dehydrogenase (LDH), glucose (Glc), and total protein (TP). CVE (0.05-0.15 g/kg/day) was orally administered to mice. RESULTS: After 7 days, the immobility time was decreased in the 0.1- and 0.15-g/kg CVE-treated groups (179 +/- 8.3 and 175 +/- 2.1 s) in comparison with the control group (223 +/- 5.4 s). In addition, the contents of BUN, CK, and LDH in the blood serum were decreased in the CVE-fed group. However, they had no effect on the elevation of Glc and TP level. CONCLUSIONS: The results predict a potential benefit of CVE for enhancing immune function and improving physical stamina.